Deciphera Pharmaceuticals

About:

Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.

Website: http://www.deciphera.com/

Twitter/X: Deciphera

Top Investors: SV Health Investors, Sphera Global Healthcare Fund, Viking Global Investors, New Leaf Venture Partners, Redmile Group

Description:

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United Kingdom, and the United States.